Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$28,176,496
+$8,733,409 QoQ
Shares Held
1,547,309
+13.1% QoQ
Ownership
2.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. CGEM ranks #114 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,176,496 1,547,309
2026-03-31 $19,443,087 1,368,268
2025-12-31 $13,478,411 1,302,262
2025-09-30 $7,681,246 1,295,320
2025-06-30 $9,634,604 1,279,496
2025-03-31 $9,400,554 1,241,817
2024-12-31 $14,794,327 1,214,641
2024-09-30 $20,228,966 1,208,421
2024-06-30 $17,029,915 976,486
2024-03-31 $11,541,703 677,330
2023-12-31 $6,681,216 655,664
2023-09-30 $5,346,948 590,823
2023-06-30 $5,512,842 512,346
2023-03-31 $5,501,929 537,823
2022-12-31 $5,877,489 557,108
2022-09-30 $6,942,286 541,520
2022-06-30 $6,474,023 504,994
2022-03-31 $4,633,404 442,541
2021-12-31 $6,663,769 431,871
2021-09-30 $9,507,341 421,238
2021-06-30 $5,997,741 232,922
2021-03-31 $9,178,525 220,267